Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Fuji
Fish and Richardson
Baxter
Queensland Health

Generated: September 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,248,123

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,248,123 protect, and when does it expire?

Patent 9,248,123 protects CONTRAVE and is included in one NDA.

This patent has twenty patent family members in eleven countries.

Summary for Patent: 9,248,123
Title:Methods of providing weight loss therapy in patients with major depression
Abstract: Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.
Inventor(s): Dunayevich; Eduardo (San Diego, CA), Tollefson; Gary (Indianapolis, IN)
Assignee: Orexigen Therapeutics, Inc. (La Jolla, CA)
Application Number:12/987,909
Patent Claim Types:
see list of patent claims
Use; Dosage form; Composition; Formulation;

Drugs Protected by US Patent 9,248,123

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Nalpropion CONTRAVE bupropion hydrochloride; naltrexone hydrochloride TABLET, EXTENDED RELEASE;ORAL 200063-001 Sep 10, 2014 RX Yes Yes   Try a Free Trial   Try a Free Trial USE OF NALTREXONE AND BUPROPION FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Daiichi Sankyo
Covington
Queensland Health
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.